UBS ASSET MANAGEMENT AMERICAS LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,599,569
-98.4%
276,749
+2209.7%
0.00%
Q3 2022$288,287,000
+31.8%
11,9820.0%0.00%
Q2 2022$218,672,000
-59.4%
11,982
-18.2%
0.00%
Q4 2021$538,020,000
+18.3%
14,6480.0%0.00%
Q3 2021$454,820,000
+101.5%
14,648
+106.3%
0.00%
Q2 2021$225,709,0007,1000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders